Neurostimulation for Sleep Disordered Breathing (SDB)

NCT07243405 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2025-11-21

No results posted yet for this study

Summary

This is a study to determine if the Lunair Alpha System is safe and effective for treating moderate to severe sleep disordered breathing.

Conditions

Interventions

DEVICE

Neuro stimulator implant

Neuro stimulator for treating sleep disordered breathing

Sponsors & Collaborators

  • Lunair Medical

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-30
Primary Completion
2026-09-01
Completion
2027-12-31

Countries

  • Panama

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07243405 on ClinicalTrials.gov